New therapeutic targets to reduce inflammation-associated cardiovascular risk: the CCL2–CCR2 axis, LOX-1, and IRF5
Filippo Crea
Topics & Concepts
MedicineInflammationIRF5CCR2CCL2Innate immune systemImmunologyChemokineImmune systemInterferon regulatory factorsChemokine receptorAtherosclerosis and Cardiovascular DiseasesInflammatory mediators and NSAID effectsEicosanoids and Hypertension Pharmacology